Your browser doesn't support javascript.
loading
Wakabayashi & Daimon cardiometabolic index as an indicator to assess risk in adults. A systematic review.
Torres-Orozco, Anna K; De León, Lidia G; Ortiz-Rodríguez, Briseidy; Candia-Luján, Ramón.
Afiliação
  • Torres-Orozco AK; Universidad Autónoma de Chihuahua, Facultad de Ciencias de la Cultura Física, Chihuahua, Chihuahua, Mexico.
  • De León LG; Universidad Autónoma de Chihuahua, Facultad de Ciencias de la Cultura Física, Chihuahua, Chihuahua, Mexico. Electronic address: gdeleon@uach.mx.
  • Ortiz-Rodríguez B; Universidad Autónoma de Chihuahua, Facultad de Ciencias de la Cultura Física, Chihuahua, Chihuahua, Mexico.
  • Candia-Luján R; Universidad Autónoma de Chihuahua, Facultad de Ciencias de la Cultura Física, Chihuahua, Chihuahua, Mexico.
Aten Primaria ; 56(5): 102846, 2024 May.
Article em En | MEDLINE | ID: mdl-38218120
ABSTRACT

OBJECTIVE:

To analyze the Wakabayashi & Daimon (2015) equation, as a predictive indicator of cardiometabolic diseases and its comparison with other indices.

DESIGN:

A systematic review was carried out between January and March 2023, according to the PRISMA statement. DATA SOURCE Scopus, Web of Science, and PubMed databases were reviewed using "cardiometabolic index" (CMI) as the search term. STUDY SELECTION The following inclusion criteria were determined studies in adults with cardiometabolic diseases using the Wakabayashi & Daimon (2015) CMI formula in different populations; studies that validate or compare the equation or that demonstrate the effects of the intervention. DATA EXTRACTION Of the 11 selected articles, the characteristics of the population, type of study, indicators for the validation of the CMI, the reported statistics and the conclusions that were recorded in a comparative table were obtained. RESULTS AND

CONCLUSIONS:

Odds ratio, hazard ratio, sensitivity, and specificity were used to assess associations, risk, effectiveness, and validity of the tests, indicating favorable relationships between the factors analyzed and the results obtained. Validation and probabilistic analysis of the CMI were performed against diverse diseases such as obesity [Man >60y=AUC=0.90 (0.75-1.00) (p=0.01), Se=100, Sp=81.8, YI=0.82 and OR 4.66 and Women >60y=AUC=0.95 (0.88-1.00), p=0.001, Se=90.0, Sp=100, YI=0.90 and OR=36.27]; cardiovascular diseases [AUC=0.617, Se=0.675, Sp=0.509; HR=1.48 (1.33, 1.65), p=<0.001], among others. In conclusion CMI is a new utility index that broadly identifies the presence of risk that leads to cardiometabolic diseases in adults.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Revista: Aten Primaria Ano de publicação: 2024 Tipo de documento: Article País de afiliação: México País de publicação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Revista: Aten Primaria Ano de publicação: 2024 Tipo de documento: Article País de afiliação: México País de publicação: Espanha